Macroaxis: Personalized Investing
Simple Personalized Investing

ABT MDT SYK ISRG Healthcare Funds Housewares Utilities Basic Utilities 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Processing. Please wait...

Stryker insider: Allan Golston

       

Allan Golston - Stryker Insider Profile

Independent Director

Mr. Allan C. Golston is Independent Director of Stryker Corporationration, since January 1, 2011. He served as President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of MaltOMeal, a privately held breakfast cereal corporation, where he is the Chair of the Audit Committee. Mr. Golston has experience in auditing, finance and the health care industry. He is a Certified Public Accountant and has held positions as a finance executive with Swedish Health Services and the University of Colorado Hospital.
Age: 45  Director Since 2011      

Other Appointments

STRYKERSYKGermany Berlin
Director since 2011
STRYKERSYKGermany Munich
Director since 2011
STRYKERSYKGermany Frankfurt
Director since 2011

Management Efficency

The company has Return on Asset of 8.43 % which means that on every $100 spent on asset it made $8.43 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.2 % implying that it generated $15.2 on every 100 dollars invested.
The company has 2.77 B in debt with debt to equity (D/E) ratio of 0.33 which is OK given its current industry classification. Stryker Corporation has Current Ratio of 4.57 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
    

Other Executives

Curt Hartman, CEO
Kevin Lobo, CEO
William Parfet, Chairman
William Jellison, President
Steven Benscoter, President
Lonny Carpenter, President
David Furgason, President
Curtis Hall, President
Tony McKinney, President
David Floyd, President
Timothy Scannell, President
Michael Rude, President
Ramesh Subrahmanian, President
Katherine Owen, President
Scott Bruder, President, Ph.D
Roch Doliveux, Director
Howard Cox, Director
Ronda Stryker, Director
Howard Lance, Director
Srikant Datar, Director
Louise Francesconi, Director
Dean Bergy, VP
Andrew Fox-Smith, Executive

Entity Summary

Stryker Corporationration, a medical technology company, offer reconstructive, medical and surgical, and neurotechnology and spine solutions for doctors, hospitals, and other healthcare facilities. Stryker Corporation [SYK] is traded on New York Stock Exchange in USA. It is located in Kalamazoo, MI and employs 22,010 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
SYK United States NYSE
Stryker Corporation
Benchmark S&P 500
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    
Chance of
Bankruptcy
Less
Than
12%
In The Next
Two Years
Stryker Corporation has less than 12.5 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

Stryker price boundaries

    
April 24 2013
 64.79 
  
 64.73 
(0.06)  Macroaxis: -0.09260688377836436 Down   0.09%  
Lowest period price (30 days)
May 15 2013
 69.12 
  
 69.43 
0.31  Macroaxis: 0.4484953703703737 Up   0.45%  
Highest period price (30 days)
    

Promote Stryker and Allan Golston

Follow Stryker with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Stryker to your reader
 

Today Change

 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.00 % No Change  
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
 United States NYSE   0.25 % Macroaxis: 0.25 Moved Down  
 
 thisRed SYK SYK agains markets  0.37 % Macroaxis: 0.37 Moved Down  
 

Stock Performance

Shares Outstanding378.06 M
Number of Shares Shorted6.85 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium